Association of the Metabolic Syndrome with Antioxidant Defense and Outstanding Superoxide Dismutase Activity in Mexican Subjects

Metabolic Syndrome and Related Disorders

Volumn 14, Issue 3, 2016, Pages 154-160

  Baez Duarte, Blanca G ^a   Zamora Ginez, Irma ^a   De Jésus, Karina Luna ^a   Torres Rasgado, Enrique ^a   González Mejía, M Elba ^a   Porchia, Leonardo ^b   Ruiz Vivanco, Guadalupe ^a   Pérez Fuentes, Ricardo ^a,b  

^a BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; SUPEROXIDE DISMUTASE; ANTIOXIDANT;

ADULT; ARTICLE; ENZYME ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MESTIZO; METABOLIC SYNDROME X; MEXICAN; OXIDATIVE STRESS; PRIORITY JOURNAL; WAIST CIRCUMFERENCE; BLOOD; ETHNOLOGY; METABOLISM; MEXICO; MIDDLE AGED; MORPHOMETRY; PHYSIOLOGY; YOUNG ADULT;

ADULT; ANTIOXIDANTS; BODY WEIGHTS AND MEASURES; FEMALE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HUMANS; MALE; METABOLIC SYNDROME X; MEXICO; MIDDLE AGED; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; YOUNG ADULT;

EID: 84961771247     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2015.0088     Document Type: Article

References (46)

1. Gutiérrez JP, Rivera-Dommarco J, Shamah-Levy T, et al. Encuesta Nacional de Salud y Nutrición 2012. Resultados Nacionales. Cuernavaca, México: Instituto Nacional de Salud Pública; 2012.
2. Roberts CK, Sindhu KK. Oxidative stress and metabolic syndrome. Life Sci 2009;84:705-712.
3. González-Chávez A, Simental L, Elizondo-Argueta S, et al. Prevalencia del síndrome metabólico entre adultos mexicanos no diabéticos, usando las definiciones de la OMS, NCEP-ATPIIIa e IDF. Rev Med Hosp Gen Mex 2008;71: 11-19.
4. González-Chávez A, Amancio-Chassin O, Islas-Andrade S, et al. Factores de riesgo cardiovascular asociados a obesidad abdominal en adultos aparentemente sanos. Rev Med Inst Mex Seguro Soc 2008;46:273-279.
5. Bremer AA, Mietus-Snyder M, Lusting RH. Toward a unifying hypothesis of metabolic syndrome. Pediatrics 2012; 129:557-570.
6. Halliwell B. Free radicals, antioxidants, and human disease: Curiosity, cause, or consequence? Lancet 1994;344: 721-724.
7. Carrillo-Calvillo J, Bear-Sandoval IR. Biomarcadores, inflamacion, estrés oxidativo, lípidos y aterotrombosis. Arch Cardiol Mex 2004;74:S379-S384.
8. Vávrová L, Kodydková J, Zeman M, et al. Altered activities of antioxidant enzymes in patients with metabolic syndrome. Obes Facts 2013;6:39-47.
9. Ceballos-Reyes G, Ramírez-Sánchez I, Calzada-Mendoza CC, et al. Disfunción endotelial y estrés oxidativo. Rev Endoc Nutr 2006;14:233-236.
10. Esposito K, Ciotola M, Schisano B, et al. Oxidative stress in the metabolic syndrome. J Endocrinol Invest 2006;29: 791-795.
11. Jialal I, Devaraj S, Adams-Huet B, et al. Increased cellular and circulating biomarkers of oxidative stress in nascent metabolic syndrome. J Clin Endocrinol Metab 2012;97: e1844-e1850.
12. Fortuño A, San José G, Moreno MU, et al. Phagocytic NADPH oxidase overactivity underlies oxidative stress in metabolic syndrome. Diabetes 2006;55:209-215.
13. Fernández-Sánchez A, Madrigal-Santillán E, Bautista M, et al. Inflammation, oxidative stress, and obesity. Int J Mol Sci 2011;12:3117-3132.
14. Calabrese V, Cornelius C, Leso V, et al. Oxidative stress, glutathione status, sirtuin and cellular stress response in type 2 diabetes. Biochim Biophys Acta 2012;1822:729-735.
15. Jain SK, Micinski D, Huning L, et al. Vitamin D and Lcysteine levels correlate positively with GSH and negatively with insulin resistance levels in the blood of type 2 diabetic patients. Eur J Clin Nutr 2014;68:1148-1153.
16. Chen S-J, Yen C-H, Huang Y-C, et al. Relationships between inflammation, adiponectin, and oxidative stress in metabolic syndrome. PLoS One 2012;7:e45693.
17. Yokota T, Kinugawa S, Yamato M, et al. Systemic oxidative stress is associated with lower aerobic capacity and impaired skeletal muscle energy metabolism in patients with metabolic syndrome. Diabetes Care 2013;36:1341-1346.
18. Cardona F, Túnez I, Tasset I, et al. Fat overload aggravates oxidative stress in patients with the metabolic syndrome. Eur J Clin Invest 2008;38:510-515.
19. Cardona F, Túnez I, Tasset I, et al. Similar increase in oxidative stress after fat overload in persons with baseline hypertriglyceridemia with or without the metabolic syndrome. Clin Biochem 2008;41:701-705.
20. Collazo-Román M, Muñoz-Forti K, González A, et al. Levels of antioxidant activity and oxidative stress in metabolic syndrome Puerto Rican participants (1138.9). FASEB J 2014;28:1138.9.
21. Yubero-Serrano EM, Delgado-Lista J, Peña-Orihuela P, et al. Oxidative stress is associated with the number of components of metabolic syndrome: LIPGENE study. Exp Mol Med 2013;45:e8.
22. WHO. Clinical Guidelines on the identification, evaluation and treatment of overweight and obesity in adults-The Evidence Report. National Institutes of Health. Obes Res 1997;Suppl 2:51Se209S.
23. Ministry of Health. NORMA Oficial Mexicana NOM-030-1999-SSA2 for prevention, treatment and control of hypertension. Mexico City, Mexico: Ministry of Health; 1999.
24. Ministry of Health. NORMA Oficial Mexicana NOM-015-SSA2-2010 for prevention, treatment and control of diabetes mellitus. Mexico City, Mexico: Ministry of Health; 2010.
25. Ministry of Health. NORMA Oficial Mexicana NOM-037-SSA2-2002 for prevention, treatment and control of dyslipidemia. Mexico City, Mexico: Ministry of Health; 2002.
26. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143e3421.
27. Baez-Duarte BG, Sánchez-Guillén MC, Pérez-Fuentes R, et al. B-cell function is associated with metabolic syndromein Mexican subjects. Diabetes Metab Syndr Obes 2010;3:1e9.
28. Feoli AM, Macagnan FE, Piovesan CH, et al. Xanthine oxidase activity is associated with risk factors for cardiovascular disease and inflammatory and oxidative status markers in metabolic syndrome: Effects of a single exercise session. Oxid Med Cell Longev 2014;2014:587083.
29. Isogawa A, Yamakado M, Yano M, et al. Serum superoxide dismutase activity correlates with the components of metabolic syndrome or carotid artery intima-media thickness. Diabetes Res Clin Pract 2009;86:213-218.
30. Fujita K, Nishizawa H, Funahashi T, et al. Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. Cir J 2006;70:1437-1442.
31. Kobayashi H, Matsuda M, Fukuhara A, et al. Dysregulated glutathione metabolism links to impaired insulin action in adipocytes. Am J Physiol Endocrinol Metab 2009;296: e1326-e1334.
32. Roberts CK, Barnard RJ, Sindhu RK, et al. Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in diet-induced metabolic syndrome. Metabolism 2006;55:928-934.
33. Annemarie ES, Beske SD, ChristouDD, et al. Overweight and obese humans demonstrate increased vascular endothelial NAD(P)H oxidase-p47phox expression and evidence of endothelial oxidative stress. Circulation 2007;115:627-637.
34. Karaouzene N, Merzouk H, Aribi M, et al. Effects of the association of aging and obesity on lipids, lipoproteins and oxidative stress biomarkers: A comparison of older with young men. Nutr Metab Cardiovasc Dis 2011;21:792-799.
35. Matsuda M, Shimomura I. Increased oxidative stress in obesity: Implications for metabolic syndrome diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer. Obes Res Clin Pract 2013;7:e330-e341.
36. Guemouri L, Artur Y, Herbeth B, et al. Biological variability of superoxide dismutase, glutathione peroxidase, and catalase in blood. Clin Chem 1991;37:1932-1937.
37. Bolzan AD, Bianchi MS, Bianchi NO. Superoxide dismutase, catalase and glutathione peroxidase activities in human blood: Influence of sex, age and cigarette smoking. Clin Biochem 1997;30:449-454.
38. Ceballos-Picot I, Trivier JM, Nicole A, et al. Agecorrelated modifications of copper-zinc superoxide dismutase and glutathione-related enzyme activities in human erythrocytes. Clin Chem 1992;38:66-70.
39. Massafra C, Gioia D, De Felice C, et al. Effects of estrogens and androgens on erythrocyte antioxidant superoxide dismutase, catalase and glutathione peroxidase activities during the menstrual cycle. J Endocrinol 2000;167:447-452.
40. De Tursi-Ríspoli L, Vázquez-Tarragón A, Vázquez-Prado A, et al. Estrés oxidative; studio comparative entre un grupo de población normal y un grupo de población obesa mórbida. Nutr Hosp 2013;28:671-675.
41. Liu Y, Hyde AS, Simpson MA, et al. Emerging regulatory paradigms in glutathione metabolism. Adv Cancer Res 2014;122:69-101.
42. Lu SC. Regulation of glutathione synthesis. Mol Aspects Med 2009;30:42-59.
43. Lu SC, Ge JL, Kuhlenkamp J, et al. Insulin and glucocorticoid dependence of hepatic gamma-glutamylcysteine synthetase and glutathione synthesis in the rat. Studies in cultured hepatocytes and in vivo. J Clin Invest 1992;90:524-532.
44. Urata Y, Yamamoto H, Goto S, et al. Long exposure to high glucose concentration impairs the responsive expression of g-glutamylcysteine synthetase by interleukin-1ß and tumor necrosis factor-A in mouse endothelial cells. J Biol Chem 1996;271:15146-15152.
45. Ballatori N, Krance SM, Notenboom S, et al. Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem 2009;390:191-214.
46. Montague CT, Prins JB, Sanders L, et al. Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes 1998;47:1384e1391.